K-numberK251572
Device nameeRapid with eTrack System
ApplicantPari Respiratory Equipment, Inc.
Product codeCAF
Device classClass II
Decision dateDec 19, 2025
DecisionSubstantially Equivalent
Regulation868.5630
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The eRapid with eTrack Nebulizer System is a portable, handheld electronic nebulizer for adult and pediatric patients age 4 and older prescribed inhaled medications. It uses micro-perforated vibrating membrane (eFlow) technology to aerosolize liquid medications and is intended for use in hospitals, nursing homes, sub-acute facilities, and home environments.

Technological characteristics

The device uses identical eFlow mesh technology and handset design as the predicate eRapid NCP, with the same aerosol performance and breath-enhanced two-way valve system. Key differences are: the eTrack controller adds built-in Wi-Fi and Bluetooth wireless connectivity; the polypropylene handset material comes from a different manufacturer (Bormed); and the adhesive bonding the piezo to the substrate was changed to Delo Monopox.

Test standards cited

ANSI/AAMI ES60601-1:2005/(R)2012; IEC 60601-1-2:2014; IEC 60601-1-6:2010; IEC 60601-1-11:2015; IEC 62304; ISO 10993-1. Testing included biocompatibility, EMC, electrical safety, software validation (moderate level of concern, Class B), aerosol performance, simulated use, cleaning/disinfection validation, cybersecurity risk assessment, and wireless coexistence.

Substantial equivalence argument

The eRapid with eTrack is substantially equivalent because it maintains identical intended use, regulatory classification, operating technology, and aerosol performance as the predicate eRapid NCP. Differences (wireless connectivity, material supplier change, adhesive formulation) do not alter the fundamental mechanism of action or safety/effectiveness profile. Performance testing confirmed aerosol output, particle size, and electrical characteristics remain within acceptable tolerances identical to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →